The historic rise of Viagra has firmly established as a symbol of pharmaceutical success, yet its future within the broader sector now presents questions about future yields . Copycat versions are eroding patent protection , causing worries that betting on companies closely tied to Viagra's previous standing could be a dangerous strategy, especiall